"The Atlantic" also noted that the 2017 vaccine for the flu was only ten percent effective against H3N2 in Australia.As the typical practice of studying and creating the current vaccines in chicken eggs tends to result in mutations, 2017 was the first year that researchers used dog cells rather than chicken eggs to create the H3N2 component of the vaccine Flucelvax.